NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ – Trademark Portfolio

Entity Type: 99

NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include PURELIFE. The owner is based in İSTANBUL.

EYÜP SULTAN MAHALLESİ KALENDER SOKAK ERLOG LOJISTIK APT. NO:1/2 SANCAKTEPE

İSTANBUL 34885 , TR

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PURELIFE
PURELIFE
Registered 2025

Trademark Classifications

NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ have?

NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ file in?

NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ files trademarks across 1 Nice Classification class. The most active classes are Class 30 (Staple Foods). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.

What are NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ's most well-known trademarks?

NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ's registered trademark portfolio includes well-known marks such as PURELIFE. These are among 1 currently registered trademark in the portfolio.

What is NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ's trademark registration success rate?

NYC GIDA SANAYİ VE TİCARET ANONİM ŞİRKETİ has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.